United Therapeutics' CEO Discusses Q1 2012 Results - Earnings Call Transcript

United Therapeutics (UTHR)

Q1 2012 Earnings Call

April 26, 2012 9:00 am ET

Executives

Martine A. Rothblatt - Founder, Chairman and Chief Executive Officer

Andrew Fisher -

John M. Ferrari - Chief Financial Officer, Principal Accounting Officer and Treasurer

Roger A. Jeffs - President, Chief Operating Officer and Director

Analysts

Unknown Analyst

Roz Sweeney - RBC Capital Markets, LLC, Research Division

Joseph P. Schwartz - Leerink Swann LLC, Research Division

Liana Moussatos - Wedbush Securities Inc., Research Division

Mike Schmidt

Presentation

Operator

Compare to:
Previous Statements by UTHR
» United Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript
» United Therapeutics' CEO Discusses Q3 2011 Results - Earnings Call Transcript
» United Therapeutics Corporation Special Call

Good morning. My name is Tyrone and I'll be your conference operator today. At this time, I would like to welcome everyone to the United Therapeutics Corporation First Quarter Earnings Conference Call. [Operator Instructions] Remarks today concerning United Therapeutics will include forward-looking statements, which represent United Therapeutics' expectations or beliefs regarding future events based on current assumptions.

United Therapeutics cautions that such statements involve risks and uncertainties that may cause the actual results to differ materially from those in the forward-looking statements. Consequently, all such forward-looking statements are qualified by the cautionary language and risk factors set forth in United Therapeutics' periodic and other reports filed with the SEC. There can be no assurance that the actual results, events or developments referenced in such forward-looking statements will occur or be realized.

United Therapeutics assumes no obligations to update these forward-looking statements to reflect the actual results, changes in assumptions or changes in the factors affecting such forward-looking statements.

Thank you. Dr. Rothblatt, you may begin your conference.

Martine A. Rothblatt

Thank you very much, conference call operator. Good morning to everybody listening in on the United Therapeutics first quarter 2012 financial results conference call. I have joining me on the conference call today from United Therapeutics, our President and Chief Operating Officer, Dr. Roger Jeffs; our Chief Financial Officer, Mr. John Ferrari; and our Chief Strategy Officer, Mr. Andy Fisher.

1 2 3 Next › Last »